Thallion Pharmaceuticals News - TLN

Thallion Pharmaceuticals Announces Cash Component of $0.1889 Per Share

MONTREAL, QUEBEC--(Marketwired - Aug. 9, 2013) - Thallion Pharmaceuticals Inc. ("Thallion") (TSX VENTURE:TLN) and BELLUS Health Inc. (TSX:BLU...

Thallion Announces Shareholder Approval for Plan of Arrangement and Date and Time for the Motion for Final Court Order

MONTREAL, QUEBEC--(Marketwired - Aug. 6, 2013) - Thallion Pharmaceuticals Inc. ("Thallion") (TSX VENTURE:TLN) and BELLUS Health Inc. (TSX:BLU...

RETRANSMISSION/Thallion Pharmaceuticals Announces Minimum Effective Net Cash of $7,500,000 Resulting in Cash Component of at ...

MONTREAL, QUEBEC--(Marketwired - Aug. 2, 2013) - Thallion Pharmaceuticals Inc. ("Thallion") (TSX VENTURE:TLN) and BELLUS Health Inc. (TSX:BLU...

Thallion Pharmaceuticals Announces Minimum Effective Net Cash of $7,500,000 Resulting in Cash Component of at Least $0.1765 P...

MONTREAL, QUEBEC--(Marketwired - Aug. 2, 2013) - Thallion Pharmaceuticals Inc. ("Thallion") (TSX VENTURE:TLN) and BELLUS Health Inc. (TSX:BLU...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Thallion Pharmaceuticals (TLN)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

TLN News

Thallion Pharmaceuticals Announces Cash Component of $0.1889 Per Share

Thallion Announces Shareholder Approval for Plan of Arrangement and Date and Time for the Motion for Final Court Order

RETRANSMISSION/Thallion Pharmaceuticals Announces Minimum Effective Net Cash of $7,500,000 Resulting in Cash Component of at ...

Thallion Pharmaceuticals Announces Minimum Effective Net Cash of $7,500,000 Resulting in Cash Component of at Least $0.1765 P...

Thallion Announces 2013 Second Quarter Operating Results

RETRANSMISSION: BELLUS Health Amends Terms of CVRs in Connection With Its Acquisition of Thallion

BELLUS Health Amends Terms of CVRs in Connection With Its Acquisition of Thallion

IIROC Trading Resumption - TLN

Thallion's Annual and Special Meeting to Be Held August 6, 2013

Suspension de la négociation par l'OCRCVM - TLN

Thallion Reaffirms Support of BELLUS Health Acquisition

BELLUS Santé fera l'acquisition de Thallion Pharmaceutiques

TLN Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Thallion Pharmaceuticals (TLN) News

Thallion Pharmaceuticals (TLN)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

TLN News

Thallion Pharmaceuticals Announces Cash Component of $0.1889 Per Share

Thallion Announces Shareholder Approval for Plan of Arrangement and Date and Time for the Motion for Final Court Order

RETRANSMISSION/Thallion Pharmaceuticals Announces Minimum Effective Net Cash of $7,500,000 Resulting in Cash Component of at ...

Thallion Pharmaceuticals Announces Minimum Effective Net Cash of $7,500,000 Resulting in Cash Component of at Least $0.1765 P...

Thallion Announces 2013 Second Quarter Operating Results

RETRANSMISSION: BELLUS Health Amends Terms of CVRs in Connection With Its Acquisition of Thallion

BELLUS Health Amends Terms of CVRs in Connection With Its Acquisition of Thallion

IIROC Trading Resumption - TLN

Thallion's Annual and Special Meeting to Be Held August 6, 2013

Suspension de la négociation par l'OCRCVM - TLN

Thallion Reaffirms Support of BELLUS Health Acquisition

BELLUS Santé fera l'acquisition de Thallion Pharmaceutiques

TLN Discussion

Your Recent History